Wegovy

About

The official Novo Nordisk site for Wegovy, which is semaglutide dosed and FDA approved specifically for chronic weight management, alongside an approval to reduce cardiovascular events in adults with established cardiovascular disease and overweight or obesity. It is the same active ingredient as Ozempic at different approved dosing and for a different indication, a distinction that causes constant confusion. The site publishes full prescribing information, dose escalation schedules, and coverage tools.